{"text_format":"2","workbook":"xls","n_sheets":1,"sheets":["report2"],"not_rendered":{"charts":0,"images":0,"macros":0,"external_links":1,"defined_names":1,"comments":0,"pivot_tables":0},"unopened":[],"bounds":{"document_bytes":16777216,"sheet_cells":100000,"run_cost":"one","rows_first":2000,"rows_last":500,"rows_between":2000,"halvings":0,"cell_chars":16384,"cell_head_chars":4096},"cells_cut":0,"cells_raw":0,"read":"whole","date_system":"1900","formulas":"cached_only"}

{"sheet":"report2","index":0,"n_rows":16,"n_cols":5,"rows_kept":16,"cut":false,"hidden":false,"merged":[[0,2,0,3],[0,4,0,5],[1,2,1,3],[1,4,1,5],[2,2,2,3],[2,4,2,5],[3,2,3,3],[4,2,4,3],[5,2,5,3],[6,2,6,3],[8,2,8,3],[9,2,9,3]],"flags":["formulas_cached_only"]}
[null,"1.","Record Nr.",null,"UNINA9910696238803321"]
[null,null,"Autore",null,"Rhodes Keith A"]
[null,null,"Titolo",null,"High-containment biosafety laboratories [[electronic resource] ] : preliminary observations on the oversight of the proliferation of BSL-3 and BSL-4 laboratories in the United States : testimony before the Subcommittee on Oversight and Investigations, Committee on Energy and Commerce, House of Representatives / / statement of Keith Rhodes"]
[null,null,"Pubbl/distr/stampa",null,"[Washington, D.C.] : , : U.S. Govt. Accountability Office, , [2007]"]
[null,null,"Descrizione fisica",null,"35 pages : digital, PDF file"]
[null,null,"Collana",null,"Testimony ; ; GAO-08-108 T"]
[null,null,"Soggetti",null,"Microbiological laboratories - United States"]
[{"$nulls":4},"Medical laboratories - United States"]
[null,null,"Lingua di pubblicazione",null,"Inglese"]
[null,null,"Formato",null,"Materiale a stampa"]
[null,null,null,"Livello bibliografico","Monografia"]
[null,null,null,"Note generali","Title from title screen (viewed on Oct. 5, 2007)."]
[{"$nulls":4},"\"For release on delivery...October 4, 2007.\""]
[{"$nulls":4},"Paper version available from: U.S. Govt. Accountability Office, 441 G St., NW, Rm. LM, Washington, D.C. 20548."]
[null,null,null,"Nota di bibliografia","Includes bibliographical references."]
[null,null,null,"Sommario/riassunto","This testimony addresses (1) the extent to which there has been a proliferation of BSL-3 and BSL-4 labs, (2) federal agencies' responsibility for tracking this proliferation and determining the associated risks, and (3) the lessons that can be learned from recent incidents at three high-containment biosafety labs."]